Vantage Investment Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $12K | Hold |
300
| – | – | ﹤0.01% | 499 |
|
|
2018
Q2 | $11K | Buy |
+300
| New | +$11K | ﹤0.01% | 516 |
|
|
2018
Q1 | – | Sell |
-500
| Closed | – | – | 804 |
|
|
2017
Q4 | $0 | Buy |
500
+204
| +69% | – | ﹤0.01% | 824 |
|
|
2017
Q3 | $10K | Hold |
296
| – | – | ﹤0.01% | 558 |
|
|
2017
Q2 | $10K | Hold |
296
| – | – | ﹤0.01% | 541 |
|
|
2017
Q1 | $9K | Hold |
296
| – | – | ﹤0.01% | 548 |
|
|
2016
Q4 | $8K | Hold |
296
| – | – | ﹤0.01% | 546 |
|
|
2016
Q3 | $10K | Buy |
+296
| New | +$10K | ﹤0.01% | 487 |
|
|
2016
Q2 | – | Sell |
-330
| Closed | -$9K | – | 839 |
|
|
2016
Q1 | $9K | Buy |
330
+60
| +22% | +$1.64K | ﹤0.01% | 523 |
|
|
2015
Q4 | $9K | Hold |
270
| – | – | ﹤0.01% | 515 |
|
|
2015
Q3 | $9K | Hold |
270
| – | – | 0.01% | 508 |
|
|
2015
Q2 | $9K | Sell |
270
-330
| -55% | -$11K | 0.01% | 494 |
|
|
2015
Q1 | $21K | Buy |
600
+330
| +122% | +$11.6K | 0.01% | 484 |
|
|
2014
Q4 | $10K | Hold |
270
| – | – | 0.01% | 496 |
|
|
2014
Q3 | $10K | Hold |
270
| – | – | 0.01% | 470 |
|
|
2014
Q2 | $10K | Hold |
270
| – | – | 0.01% | 467 |
|
|
2014
Q1 | $9K | Hold |
270
| – | – | 0.01% | 437 |
|
|
2013
Q4 | $8K | Buy |
+270
| New | +$8K | 0.01% | 420 |
|